Metro Healthcare Bhd (XKLS:0329) ROCE %: 5.87% (As of Mar. 2026)


XKLS:0329 Metro Healthcare Bhd XKLS:0329
59 GF Score
Price RM0.22
GF Value RM0.32
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Metro Healthcare Bhd ROCE %?

Metro Healthcare Bhd XKLS:0329 59 ROCE % is 5.87% as of Mar. 2026. GuruFocus rates XKLS:0329 with a GF Score™ of 59/100 and a GF Value™ of RM0.32 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Metro Healthcare Bhd's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.87%.

Metro Healthcare Bhd  (XKLS:0329) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Metro Healthcare Bhd ROCE % Related Terms

Metro Healthcare Bhd ROCE % Historical Data

* Premium members only.

The historical data trend for Metro Healthcare Bhd's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metro Healthcare Bhd ROCE % Chart

Metro Healthcare Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.87 17.10 18.60 10.90 9.89

Metro Healthcare Bhd Quarterly Data
Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.46 8.58 13.89 14.05 5.87
XKLS:0329
59GF Score
Metro Healthcare Bhd XKLS:0329
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metro Healthcare Bhd ROCE % Calculation

Metro Healthcare Bhd's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=8.788/( ( (96.032 - 5.724) + (92.525 - 5.031) )/ 2 )
=8.788/( (90.308+87.494)/ 2 )
=8.788/88.901
=9.89 %

Metro Healthcare Bhd's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=5.28/( ( (92.525 - 5.031) + (100.792 - 8.237) )/ 2 )
=5.28/( ( 87.494 + 92.555 )/ 2 )
=5.28/90.0245
=5.87 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 5.87% mean?
Metro Healthcare Bhd (XKLS:0329) has a ROCE % of 5.87% as of Mar. 2026.
Is Metro Healthcare Bhd's ROCE % too high?
Metro Healthcare Bhd's current ROCE % is 5.87%. The Healthcare Providers & Services industry median ROCE % is 6.41. Metro Healthcare Bhd's value of 5.87% is 8.4% below this industry median. Overall, Metro Healthcare Bhd has a GF Score™ of 59/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Metro Healthcare Bhd's ROCE % compare to HCA and THC?
Metro Healthcare Bhd's ROCE % of 5.87% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Metro Healthcare Bhd's value of 5.87% is 8.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 643 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Metro Healthcare Bhd's current ROCE % of 5.87% is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Metro Healthcare Bhd's current ROCE % is 5.87%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metro Healthcare Bhd stock overvalued right now?
Based on GuruFocus' analysis, Metro Healthcare Bhd (XKLS:0329) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.32, compared to a current price of RM0.22 — trading 32.8% below its estimated fair value. The current ROCE % is 5.87% and 8.4% below the Healthcare Providers & Services industry median of 6.41. Metro Healthcare Bhd's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Metro Healthcare Bhd (XKLS:0329), the current ROCE % is 5.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metro Healthcare Bhd (XKLS:0329) Overvalued in 2026?

Based on GuruFocus' analysis, Metro Healthcare Bhd stock appears to be undervalued. The current stock price of RM0.22 is trading 32.8% below its estimated GF Value™ of RM0.32. GuruFocus considers Metro Healthcare Bhd to be Possible Value Trap.

Key valuation signals for XKLS:0329:

  • ROCE %: 5.87%
  • GF Value™: RM0.32 vs. price of RM0.22 (32.8% below fair value)
  • GF Score™: 59/100 with 4 warning signs
  • Industry Position: 8.4% below the Healthcare Providers & Services median

No single metric tells the full story. See the XKLS:0329 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Metro Healthcare Bhd Business Description

Address No. 32, Jalan Pasar, Klang, SGR, MYS, 41400
Metro Healthcare Bhd is engaged in the provision of women healthcare services. The company offers various services such as obstetrics, gynecology impatient services, and diagnostic medical imaging services. It also provides semen analysis, intracytoplasmic sperm injection, blastocyst culture, assisted hatching, frozen embryo transfer, preimplantation genetic screening, and infertility consultation services. The company serves patients in Malaysia. The firm's business segment includes O&G healthcare services, Complementary services, and Hospital services.
59GF Score

Get the complete analysis for XKLS:0329

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.22
Price
RM0.32
GF Value